Journal of the American Academy of Dermatology
Volume 48, Issue 6 , Pages 836-845, June 2003

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from two vehicle-controlled, randomized phase III studies☆☆☆★★★

Presented in abstract form at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, California, March 21-26, 2003.

Hershey, Pennsylvania, Montville, New Jersey, and Berlin, Germany

From Pennsylvania State University College of Medicine, Hershey,a Clinical Development, Berlex Laboratories, Montville,b and Clinical Development, Dermatology, Schering AG, Berlin.c

Accepted 3 January 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by Berlex Laboratories.

☆☆ Disclosure: Dr Thieroff-Ekerdt is an employee of Berlex Laboratories. Dr Graupe is an employee of Schering AG. Dr Thiboutot received financial compensation from Berlex Laboratories for her role as a principal investigator in these studies.

★ Reprint requests: Diane Thiboutot, MD, Department of Dermatology, Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, UPC-2, Room 4300, 500 University Dr, Hershey, PA 17033.

★★ 0190-9622/2003/$30.00 + 0

PII: S0190-9622(03)00405-5

doi:10.1067/mjd.2003.308

Journal of the American Academy of Dermatology
Volume 48, Issue 6 , Pages 836-845, June 2003

Article Tools

* Image Usage & Resolution